Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome

This study has been completed.

Study NCT00044382 Information provided by Celgene Corporation

First Received: August 27, 2002 Last Updated: June 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2005
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)